Print Page | Sign In | Join Today
VABIO E-News November 19, 2014
Share |
Email not looking beautiful? View it in your browser

Become a Member

VABIO E-News: November 19, 2014 Edition

Focus Around Virginia 
A Word from CEO Jeff Gallagher

Members and friends of Virginia Bio,

A sage once noted that " ’luck’ is where preparation meets opportunity.”

Start preparing now for the tremendous opportunity in San Francisco during JP Morgan Healthcare Conference week, January 12-16, 2015. Virginia Bio will be there to help you.

One frequently voiced concern about developing and commercializing bioscience innovation in Virginia is distance from a critical mass of investors and business development VPs. Think Boston. Well, for one week we know where they will be, and you can be there too.

Many thousands of bioscience industry movers and shakers from around the world will encamp around Union Square to do deals, make new contacts, and keep old contacts alive. They’ll be anchored by the invitation-only 33rd annual JP Morgan Healthcare Conference at the Westin St. Francis, San Francisco, and attend other high powered industry conferences that have sprung up around the fringe. 

For complete article click here.

Thank you to our Premium Partners

Chairman's Circle:


Gold Partners:

Silver Partners:

Virginia Tech Fralin Life Science Institute            VWR

In this issue
focus around Virginia
VABIO Articles
VABIO Community News
VABIO Anniversaries
VABIO Calendar


VABIO Community News 
VABIO Member Anniversaries 

VABIO Events
Virginia Bio Calendar


Apply Now For 2015 CRCF Grants

The Center for Innovative Technology (CIT) opened solicitation on November 14, 2014 for the Commonwealth Research Commercialization Fund (CRCF) Request for Proposals (RFP) for FY2015. The Letter of Intent (LOI) deadline is Tuesday, December 16, 2014 and the complete application due Friday, January 30, 2015. Award announcements are planned for early June 2015.

For complete article click here.

Cadence, Inc. First Nine Months of 2014 Results

Cadence, Inc.’s unaudited results for the first nine months of 2014 include a 37% increase in revenue compared to 2013 to $54.5 million. Net income and earnings per share increased 62% over prior year to $2.42 per share. Earnings before interest, taxes, depreciation and amortization (EBITDA) were up 32% to $11 million. 2014 results include two months from the recent acquisition announcement from Plainfield Precision Holdings of locations in Sturgeon Bay, WI, Plymouth, MA; and Santo Domingo, Dominican Republic.                        

For complete article click here.

Kaléo Donates Opioid Overdose Treatment To Law Enforcement

Kaléo is starting a new donation program that will allow qualifying local law enforcement agencies to receive EVZIO™ naloxone auto-injectors without charge as part of the kaléo Cares program.

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. EVZIO is the first and only naloxone product approved for emergency therapy in any settings where opioids may be present, including outside of supervised medical settings. EVZIO is not a substitute for emergency medical care.

For complete article click here.

UniTao Pharmaceuticals Purchases Boehringer Ingelheim Plant

Governor Terry McAuliffe announced that UniTao Pharmaceuticals LLC has purchased the Boehringer Ingelheim plant in the City of Petersburg, and will invest $22.5 million to establish operations. UniTao is a subsidiary of Shanghai-based Tenry Pharmaceutical Co., Ltd., and the company manufactures active pharmaceutical ingredients. The project is a result of the Governor’s meeting with company officials in Shanghai, China during his Asia Marketing Mission. Virginia successfully competed against California and China for the project, which will create 376 new jobs.

For complete article click here.

Aperiomics Launches First Commercial Services

Aperiomics, bearing a name based on the Latin word aperio (which means to reveal), introduced its breakthrough Absolute-NGS™ Pathogen Detection Platform to the Association for Molecular Pathology at the AMP 2014 Annual Meeting held November 12-15 near Washington, D.C.

The package includes three next-generation sequencing services to provide laboratories, public health care, and businesses the tools they need to make rapid and exact identification of known and unknown pathogens, whether bacteria, virus, fungus, or parasite. Their unique process addresses the biggest challenge in applying next-generation sequencing to real-world analysis – making sense of the massive amount of data spawned by next generation sequencing.

For complete article click here.

Bob Skunda Joins McGuireWoods Consulting

McGuireWoods Consulting had Robert T. Skunda join the firm as a Senior Consultant of Infrastructure & Economic Development. Skunda recently retired as the President and C.E.O. of the Virginia Biotechnology Research Park (VBRP) in Richmond and is a former Secretary of Commerce and Trade for the Commonwealth of Virginia.

For complete article click here.

Polymer Solutions Is Moving

Polymer Solutions will be moving into a new, custom-designed, state-of-the-art testing facility and company headquarters in Christiansburg, VA. The targeted move date is January 12, 2015.

Jim Rancourt, Ph.D, Founder and CEO, said, "We are moving so we can better align our processes with our clients’ needs. We are also moving to enhance our effectiveness as a team. We understand each of our clients have unique needs; we will strive to meet those needs. We are planning and preparing in such a way that our clients will feel little to no impact.”

For complete article click here.

NOVA Investing Over $2.2 Million In STEM

Northern Virginia Community College (NOVA) plans to invest over $2.2 million in a new college-wide initiative to persuade more students to pursue Science, Technology, Engineering and Math (STEM) two- and four-year degrees.

With funding support from the Virginia Community College System over the next three years, NOVA will invest in equipment and faculty development to ensure students receive the most current approaches to STEM training. Students in STEM courses will have access to electron scanning microscopes, atomic force microscopes and other leading edge technologies. Each of NOVA’s six campuses will designate a STEM flagship program that will receive additional resources.

For complete article click here.

VCU Students Win At 2014 Annual BMES

Student, faculty and staff representatives from the VCU Department of Biomedical Engineering joined approximately 3,600 of their contemporaries, presenters, and keynote speakers in San Antonio for the October 2014 Biomedical Engineering Society Annual Meeting (BMES).

Of the twenty-eight students traveling, eight Biomedical Engineering (BME) students took home awards and special accolades, making VCU the recipient of 30% of all undergraduate research awards won.

For complete article click here.

HemoShear Partnerships For RA Drugs Vascular Health Benefits And Rare Disease Drug Discovery

HemoShear and Janssen Research and Development (Janssen) will report data showing that a subset of compounds used to treat rheumatoid arthritis (RA) also suppress inflammation and have the potential to promote vascular health.

Data will be discussed in a joint poster presentation at the American College of Rheumatology Annual Meeting in Boston, MA on November 14-19, 2014.

For complete article click here.

Additionally, HemoShear and Children's National Health System (CNHS) together presented at the 6th annual Partnering for Cures conference held November 16-18, 2014 in New York City. Marshall Summar, MD, Division Chief of Genetics and Metabolism at CNHS, and Brian Wamhoff, PhD, Vice President of R&D and Co-founder of HemoShear, introduced a new paradigm for enabling discovery of new rare disease treatments in less time and with higher success rates.

For complete article click here.

4th Annual Pediatric Device Innovation Competition

The Atlantic Pediatric Device Consortium (APDC) is accepting proposals for its 4th annual Pediatric Device Innovation Competition. This seed grant competition is an opportunity for the scientific and business community including entrepreneurs, clinicians, scientists, businesses, academic researchers and medical and engineering graduate and undergraduate students, to develop and commercialize a pediatric medical device.

For complete article click here.

Welcome New Member: A&G Technology
Adams & Garth is a 25 year old Finance and Technology locally-owned and independent consulting and staffing firm based in Richmond, VA. Adams & Garth has been supporting the bio-technology and healthcare industries in Virginia and nationally for over a decade in the areas of Finance and IT.

For more information please visit their website.

Welcome New Member: Tympanogen

Tympanogen, LLC is a medical device company whose mission is to set a new standard of care for treating chronic tympanic membrane perforations - persistent holes in the eardrum. Tympanogen is developing and commercializing a gel patch product, called Perf-Fix, for nonsurgical repair of tympanic membrane perforations.

For more information please visit their website.

Welcome New Member: Virginia Beach Economic Development

The Virginia Beach Department of Economic Development (VBDED) is charged with expanding and diversifying the tax base and employment opportunities for the city through business development. In addition, the Virginia Beach Department of Economic Development assists the business community by providing management, technical, and other resources. In 2013, the VBDED recorded the creation of more than 2,200 new jobs, a 100% increase from the previous fiscal year. The City also brought in $260 million in new capital investment.

For more information please visit their website.

VABIO Community News TO TOP

The City of Danville extends its sincere thanks to Virginia Bio and to Engineered Biopharmaceuticals for a great event at BioTeach on October 9th. It is this kind of promotion that will encourage our teachers and students to pursue a career in STEMH. We need to foster that route to workforce training at every opportunity.
SpherIngenics recently won a presentation award at the International Society of Aesthetic and Plastic Surgeons (ISAPS) meeting in Brazil. Christopher Dosier, PhD is enrolled in the VCU Executive MBA program with a concentration in healthcare management in conjunction with the VCU Allied School of Health. Dr. Dosier will also be presenting SpherIngenics technology at the New England Venture Summit in Boston on December 10th.

Data Blueprint is proud to announce that the following consultants have recently earned the highly-respected Certified Data Management Professionals (CDMP) designation: Mike Fulmore, Bryan Hogan, and Chelsea Wilson. This prestigious certification is awarded to individuals who qualify based on a combination of criteria, including education, professional experience, and a series of test-based examinations.

C3 Nexus won the Innovation Award, presented by the Greater Richmond Chamber of Commerce on November 12, 2014. The Innovation Award recognizes emerging companies between 2 and 5 years old that are demonstrating amazing growth, innovation and potential.

VABIO Member Anniversaries TO TOP

Virginia Bio would like to thank our long term members who have recently celebrated their membership anniversaries:


Virginia Bio would also like to thank our members renewing for the first time:



Event: CIT Funding Sources Lunch & Learns
Where: Norfolk, Richmond & McLean
Details: For additional information visit their website:

Event: Virginia Bio Commercialization Luncheon
Where:  Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, December 11, 11:30 am - 1:30 pm
Title: 18 Month Report: Life science technologies, commercialization and industry partnerships from VCU Engineering School
Registration:  Click here to register
Sponsors: Data Blueprint, Greater Richmond Partnership, McGuireWoods, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

Event: CBIC and VABIO Co-hosted Holiday Social
Where:  Glass Haus Kitchen, Charlottesville, VA
When: Tuesday, December 16, 5:00 pm - 8:00 pm
Details: Join us to meet, mingle & jingle and raise a glass to toast our region's entrepreneurial and high-tech advances. This annual holiday social weaves together our various entrepreneurial and high-tech professionals who are collectively building the Charlottesville region's tech and knowledge-based economy, startup ventures, and biotech hub.
Registration:  Click here to register. Earlybird rates: $20 for members of CBIC and VABIO; $30 for non-members (increase after 12/12)

Event: How to Win SBIR/STTR Funding Workshop
Where: Richmond, VA
For additional infformation visit their website:

Event: Virginia Bio Commercialization Luncheon

Where:  Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, January 8, 11:30 am - 1:30 pm
Title: Licensing biomedical technology - dispatches from the dealmakers
Registration:  Click here to register
Sponsors: Data Blueprint, Greater Richmond Partnership, McGuireWoods, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

Event: Virginia Bio in San Francisco during JP Morgan Healthcare Conference

Where:  Eno Wine Bar, 320 Geary St, San Francisco, CA
When: Sunday, January 11, 4:00 pm - 7:00 pm
Details: Building on the success of last year's event, Virginia Bio will be hosting a reception for all members and guests, including professionals from around the country with ties to the Commonwealth, who are in San Francisco during the conference. There will also be a suite available Monday through Wednesday where members may reserve complimentary private meeting space, coffee and sodas will be available in the suite.
Registration:  Registration for Reception and Meetings coming soon
Sponsorships are now available, email us for more information

Event: VABIO Biotech and Beer Legislative Reception
Where: kaléo, Inc., Richmond, VA
When: Thursday, February 12, 5:00 pm - 7:00 pm
Details: Join the lively conversation at Biotech and Beer. Meet old friends and new colleagues in the life science community, along with state officials. Complimentary admission for all bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.
Registration: Click here to register

Event: Virginia Bio Commercialization Luncheon
Where:  Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, February 19, 11:30 am - 1:30 pm
Title: Finding and Working with an Investment Banker (plus updates from January's 32nd Annual JP Morgan Health Care Conference).
Registration:  Click here to register
Sponsors: Data Blueprint, Greater Richmond Partnership, McGuireWoods, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park  

Where:  Westfields Marriott Dulles, Chantilly VA
When: Thursday, April 23
Details: Leaders from bioscience companies, research universities, government, the investment community, entrepreneurs and professional services firms will gather from across Virginia to achieve a forward looking focus for Virginia bioscience.
Additional information to be provided soon.
Sponsorships now available. Visit our website for more information.

Virginia Bio, was formed in 1992 and incorporated in the Commonwealth of Virginia as a non-profit association. The purpose of the Association is to promote the biotechnology industry in Virginia, expand the knowledge and expertise of Virginia's businesses concerning biotechnology through seminars, educational publications and other means, to enhance public awareness of the biotechnology industry in Virginia and the scientific, economic and other benefits it provides, and to represent the interests of the biotechnology industry in Virginia before federal, state and local legislators and regulators.  We provide a forum for members and their guests to get to know each other and the many bioscience companies operating today in Virginia and serving our biotech community. We coordinate information among the many agencies and organizations interested in biotechnology.

To learn more about Virginia Bio and how you can get involved, Click Here

This email was sent to '' from Virginia Bio. If you wish to stop receiving email from us, you can simply remove yourself by clicking here.
 In order to continue receiving emails from Virginia Bio, please add to your safe sender list.

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected